Literature DB >> 24390962

Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway.

Qingming Meng1, Tongle Zhi, Yuewen Chao, Er Nie, Xuebin Xu, Qiong Shi, Lei Hua, Lei Wang, Wenjian Zhan, Yong Wang, Xiuping Zhou, Rutong Yu.   

Abstract

Glioblastoma is the most common and fatal human brain malignancy in adults with highly proliferative capacity. Despite advances in surgery and adjuvant therapy, the median survival of patients has changed little over recent decades. Identifying molecules critical for glioma development is significant for devising effective targeted therapy. We previously reported that Bex2, a member of the brain expressed X-linked gene family, promoted the progression of glioma by promoting cell proliferation. In the present study, we investigated the main mechanism of Bex2 promoting the proliferation of glioblastoma cells. We found that Bex2 downregulation inhibited glioma cell proliferation and the expression of NF-κB p65, but Bex2 overexpression promoted them. Similarly, the proliferation of glioma cells was inhibited by p65 downregulation but increased by p65 overexpression. In addition, Bex2 overexpression-induced cell proliferation was abolished by p65 downregulation. Furthermore, Bex2 with nuclear localization signal deleted no longer promoted p65 expression. In conclusion, this study demonstrates that Bex2 promotes proliferation of human glioblastoma cells via NF-κB signaling pathway and Bex2 nuclear location is critical for p65 expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390962     DOI: 10.1007/s12031-013-0215-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  37 in total

1.  Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.

Authors:  Greg Foltz; Gi-Yung Ryu; Jae-Geun Yoon; Timothy Nelson; Jessica Fahey; Amanda Frakes; Hwahyung Lee; Lorie Field; Kaitlin Zander; Zita Sibenaller; Timothy C Ryken; Rajeev Vibhakar; Leroy Hood; Anup Madan
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

2.  Characterization of the Bex gene family in humans, mice, and rats.

Authors:  Enrique Alvarez; Wenbo Zhou; Samir E Witta; Curt R Freed
Journal:  Gene       Date:  2005-08-29       Impact factor: 3.688

3.  Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

Authors:  Stuart A Grossman; Xiaobu Ye; Steven Piantadosi; Serena Desideri; Louis B Nabors; Myrna Rosenfeld; Joy Fisher
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

Review 4.  [Transcriptomic regulation and molecular mechanism of polygenic tumor at different stages].

Authors:  Xiayu Li; Shourong Shen; Minghua Wu; Xiaoling Li; Wei Xiong; Jianhong Lu; Ming Zhou; Jian Ma; Juanjuan Xiang; Zhaoyang Zeng; Bo Xiang; Yanhong Zhou; Lan Xiao; Houde Zhou; Songqing Fan; Guiyuan Li
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-07

Review 5.  Aberrant rel/nfkb genes and activity in human cancer.

Authors:  B Rayet; C Gélinas
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 6.  Protein prenylation: molecular mechanisms and functional consequences.

Authors:  F L Zhang; P J Casey
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

Review 7.  Nerve growth factor-dependent regulation of NADE-induced apoptosis.

Authors:  Jun Mukai; Petro Suvant; Taka-Aki Sato
Journal:  Vitam Horm       Date:  2003       Impact factor: 3.421

Review 8.  NF-kappaB and cancer-identifying targets and mechanisms.

Authors:  Willscott E Naugler; Michael Karin
Journal:  Curr Opin Genet Dev       Date:  2008-04-24       Impact factor: 5.578

9.  Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression.

Authors:  Marie Le Mercier; Shannon Fortin; Véronique Mathieu; Isabelle Roland; Sabine Spiegl-Kreinecker; Benjamin Haibe-Kains; Gianluca Bontempi; Christine Decaestecker; Walter Berger; Florence Lefranc; Robert Kiss
Journal:  Neoplasia       Date:  2009-05       Impact factor: 5.715

10.  Human Bex2 interacts with LMO2 and regulates the transcriptional activity of a novel DNA-binding complex.

Authors:  Chunyu Han; Hao Liu; Jin Liu; Kang Yin; Yi Xie; Xiao Shen; Yong Wang; Jiangang Yuan; Boqing Qiang; Yong-Jian Liu; Xiaozhong Peng
Journal:  Nucleic Acids Res       Date:  2005-11-24       Impact factor: 16.971

View more
  10 in total

1.  Identification of Immune-Associated Genes in Diagnosing Aortic Valve Calcification With Metabolic Syndrome by Integrated Bioinformatics Analysis and Machine Learning.

Authors:  Yufei Zhou; Wenxiang Shi; Di Zhao; Shengjue Xiao; Kai Wang; Jing Wang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 2.  Targeting adaptive glioblastoma: an overview of proliferation and invasion.

Authors:  Qian Xie; Sandeep Mittal; Michael E Berens
Journal:  Neuro Oncol       Date:  2014-07-30       Impact factor: 12.300

3.  Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.

Authors:  Tara A Barone; Catherine A Burkhart; Alfiya Safina; Gary Haderski; Katerina V Gurova; Andrei A Purmal; Andrei V Gudkov; Robert J Plunkett
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

4.  ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Fengqi Zhou; Yingyi Wang; Ning Liu; Junxia Zhang
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

5.  PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway.

Authors:  Alexander Brobeil; Fabian Kämmerer; Claudia Tag; Klaus Steger; Stefan Gattenlöhner; Monika Wimmer
Journal:  Biomolecules       Date:  2015-04-16

6.  Brain expressed and X-linked (Bex) proteins are intrinsically disordered proteins (IDPs) and form new signaling hubs.

Authors:  Eva M Fernandez; María D Díaz-Ceso; Marçal Vilar
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

7.  BEX2 promotes tumor proliferation in colorectal cancer.

Authors:  Yeting Hu; Qian Xiao; Haiyan Chen; Jinjie He; Yinuo Tan; Yue Liu; Zhanhuai Wang; Qi Yang; Xiangfeng Shen; Yu Huang; Ying Yuan; Kefeng Ding
Journal:  Int J Biol Sci       Date:  2017-02-12       Impact factor: 6.580

8.  Silencing of brain-expressed X-linked 2 (BEX2) promotes colorectal cancer metastasis through the Hedgehog signaling pathway.

Authors:  Yinuo Tan; Yeting Hu; Qian Xiao; Yang Tang; Haiyan Chen; Jinjie He; Liubo Chen; Kai Jiang; Zhanhuai Wang; Ying Yuan; Kefeng Ding
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

9.  Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury.

Authors:  Zhongyuan Bao; Yinlong Liu; Binglin Chen; Zong Miao; Yiming Tu; Chong Li; Honglu Chao; Yangfan Ye; Xiupeng Xu; Guangchi Sun; Pengzhan Zhao; Ning Liu; Yan Liu; Xiaoming Wang; Sin Man Lam; Valerian E Kagan; Hülya Bayır; Jing Ji
Journal:  Nat Commun       Date:  2021-07-09       Impact factor: 14.919

10.  Antitumor effects of curcumin on the proliferation, migration and apoptosis of human colorectal carcinoma HCT‑116 cells.

Authors:  Lei Xiang; Bin He; Qiang Liu; Dongdong Hu; Wenjing Liao; Ruochan Li; Xinyi Peng; Qian Wang; Gang Zhao
Journal:  Oncol Rep       Date:  2020-09-14       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.